Serge Weinberg

Annual General Meeting of April 30, 2021

Retrieved on: 
Friday, April 30, 2021
Articles, Companies, Business, Corporate law, CAC 40, Sanofi, Serge Weinberg, Board of directors

b'Annual General Meeting of April 30, 2021\nDividend of \xe2\x82\xac3.20 per share payable as of May 7, 2021\nParis, France \xe2\x80\x93 April 30, 2021 \xe2\x80\x93 The Combined General Shareholders\xe2\x80\x99 Meeting of Sanofi was held on April 30, 2021, without the physical presence of its shareholders, in accordance with the derogating measures adapting the rules governing the deliberation of general meetings taken by the French authorities as part of the fight against COVID-19, at the Company\xe2\x80\x99s registered office in Paris, under the chairmanship of Serge Weinberg.

Key Points: 
  • b'Annual General Meeting of April 30, 2021\nDividend of \xe2\x82\xac3.20 per share payable as of May 7, 2021\nParis, France \xe2\x80\x93 April 30, 2021 \xe2\x80\x93 The Combined General Shareholders\xe2\x80\x99 Meeting of Sanofi was held on April 30, 2021, without the physical presence of its shareholders, in accordance with the derogating measures adapting the rules governing the deliberation of general meetings taken by the French authorities as part of the fight against COVID-19, at the Company\xe2\x80\x99s registered office in Paris, under the chairmanship of Serge Weinberg.
  • All resolutions submitted to the vote were adopted by the shareholders.\nThe General Meeting approved the individual Company and consolidated financial statements for the fiscal year 2020.
  • The Board of Directors remains for a large majority comprised of Independent Directors.\nThe voting results and the videocast of the Annual General Meeting are available on:\nSanofi is dedicated to supporting people through their health challenges.
  • We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering.

Sanofi’s Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members

Retrieved on: 
Wednesday, March 3, 2021
Serge Weinberg

Moreover, Laurent Attal, after serving on the Board of Directors for 9 years, has declared his intention to retire and as a result to resign from his mandate as a Board Member before that General Meeting.

Key Points: 
  • Moreover, Laurent Attal, after serving on the Board of Directors for 9 years, has declared his intention to retire and as a result to resign from his mandate as a Board Member before that General Meeting.
  • In addition to his duties, Christian Brandts is pursuing his research activities focused mainly on translational cancer research and personalized oncology.
  • The arrivals of Christian Brandts and Barbara Lavernos will strengthen the Board of Directors expertise in technology and science, notably in the field of oncology.
  • The Board of Directors thus continues to diversify its profiles and competencies, in line with its roadmap, said Serge Weinberg, Chairman of the Board of Directors.

Dr. Jean-Christophe Rufin appointed President of the Sanofi Espoir Corporate Foundation

Retrieved on: 
Friday, September 18, 2020
Writers, Companies, CAC 40, Sanofi, Serge Weinberg, Jean-Christophe, French people

PARIS September 18, 2020 - Sanofi today announced the appointment of Dr. Jean-Christophe Rufin as President of the Sanofi Espoir Corporate Foundation.

Key Points: 
  • PARIS September 18, 2020 - Sanofi today announced the appointment of Dr. Jean-Christophe Rufin as President of the Sanofi Espoir Corporate Foundation.
  • "We are delighted that Dr. Jean-Christophe Rufin has accepted to serve as President of the Sanofi Espoir Foundation", said Serge Weinberg, President of Sanofi.
  • At the end of 2019, the Foundation was coordinating 77 projects in 50 countries in four main areas of focus:
    "It is a great honor for me to preside over the Sanofi Espoir Foundation," said Dr. Jean-Christophe Rufin.
  • Created in 2010, the Sanofi Espoir Corporate Foundation aims to reduce inequalities in health in France and internationally.